SarahACooleyMD

PubMed

• 7 citations
  Infusion reactions in natural killer cell immunotherapy: a retrospective review
  Tewodros Mamo, Shelly M. Williams, Stephanie Kinney, Katelyn M. Tessier, Todd E. DeFor, Sarah Cooley, Jeffrey S. Miller, David H. McKenna> ;Cytotherapy. 2021 Jul 1
• 7 citations
  Following Transplantation for Acute Myelogenous Leukemia, Donor KIR Cen B02 Better Protects against Relapse than KIR Cen B01.
  Lisbeth A. Guethlein, Niassan Beyzaie, Neda Nemat-Gorgani, Tao Wang, Vidhyalakshmi Ramesh, Wesley M. Marin, Jill A. Hollenbach, Johannes Schetelig, Stephen R. Spellman...> ;Journal of Immunology. 2021 Jun 11
• 11 citations
  Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple Myeloma.
  Aimee M. Merino, Rohtesh S. Mehta, Xianghua Luo, Hansol Kim, Todd E. De For, Murali Janakiram, Sarah Cooley, Rose Wangen, Frank Cichocki, Daniel J. Weisdorf, Jeffrey S...> ;Transplantation and Cellular Therapy. 2021 Apr 1
• Monocyte subpopulation recovery as predictors of hematopoietic cell transplantation outcomes.
  Turcotte, L. M.,Cao, Q.,Cooley, S. A.,Curtsinger, J.,Holtan, S. G.,Luo, X.,Yingst, A.,Weisdorf, D. J.,Blazar, B. R.,Miller, J. S.,Wagner, J. E.,Verneris, M. R.> ;Biol. Blood Marrow Transplant.. 2019 Jan 10
• Adaptive NK cell reconstitution is associated with better clinical outcomes.
  Cichocki, F.,Taras, E.,Chiuppesi, F.,Wagner, J. E.,Blazar, B. R.,Brunstein, C.,Luo, X.,Diamond, D. J.,Cooley, S.,Weisdorf, D. J.,Miller, J. S.> ;JCI Insight. 2019 Jan 25
• Donor killer-cell immunoglobulin-like receptor (KIR) genotype does not improve graft-versus-leukemia responses in chronic lymphocytic leukemia (CLL) after unrelated do...
  Bachanova, V.,Weisdorf, D. J.,Wang, T.,Marsh, SGE.,Cereb, N.,Haagenson, M. D.,Spellman, S. R.,Lee, S. J.,Guethlein, L. A.,Parham, P.,Miller, J. S.,Cooley, S. A.> ;Biol. Blood Marrow Transplant.. 2018 Dec 31
• Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control.
  Grzywacz, B.,Moench, L.,McKenna, D.,Tessier, K. M.,Bachanova, V.,Cooley, S.,Miller, J. S.,Courville, E. L.> ;J. Immunother.. 2018 Nov 30
• KIR Donor Selection: Feasibility in Identifying Better Donors
  Daniel Weisdorf, Tao Wang, Jeffrey Miller, Sarah Cooley, Steven Devine> ;Biology of Blood and Marrow Transplantation. 2018 Aug 28
• Reduced Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long Term Follow-Up
  Nelli Bejanyan, Arne Slungaard, Daniel Weisdorf, Bruce R Blazar, Shernan Holtan, Aleksandr Lazaryan, Armin Rashidi, Erica Dahl Warlick, Sarah Cooley, Celalettin Ustun,...> ;Biology of Blood and Marrow Transplantation. 2018 Aug 05
• 161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS.
  Sarhan, D.,Brandt, L.,Felices, M.,Guldevall, K.,Lenvik, T.,Hinderlie, P.,Curtsinger, J.,Warlick, E.,Spellman, S. R.,Blazar, B. R.,Weisdorf, D. J.,Cooley, S.,Vallera, D...> ;Blood Adv. 2018 Jun 27
• 87 citations
  Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.
  Sarah Cooley, Peter Parham, Jeffrey S. Miller> ;Blood. 2018 Mar 8
• Early Reconstitution of NK and Γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy
  John Wagner, Sarah Cooley, Jeffrey S Miller> ;Biology of Blood and Marrow Transplantation. 2018 Mar 06
• Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells.
  Bachanova, V.,Sarhan, D.,DeFor, T. E.,Cooley, S.,Panoskaltsis-Mortari, A.,Blazar, B. R.,Curtsinger, J. M.,Burns, L.,Weisdorf, D. J.,Miller, J. S.> ;Cancer Immunol. Immunother.. 2017 Dec 09
• 257 citations
  First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
  Rizwan Romee, Sarah Cooley, Melissa M. Berrien-Elliott, Peter Westervelt, Michael R. Verneris, John E. Wagner, Daniel J. Weisdorf, Bruce R. Blazar, Celalettin Ustun, T...> ;Blood. 2018 Jun 7
• 13 citations
  Recipient T Cell Exhaustion and Successful Adoptive Transfer of Haploidentical Natural Killer Cells.
  Robin Williams, Sarah Cooley, Veronika Bachanova, Bruce R. Blazar, Daniel J. Weisdorf, Jeffrey S. Miller, Michael R. Verneris> ;Biology of Blood and Marrow Transplantation. 2017 Nov 1
• 117 citations
  Complete remission with reduction of high-risk clones following haploidentical NK-cell therapy against MDS and AML
  Andreas T. Björklund, Mattias Carlsten, Ebba Sohlberg, Lisa L. Liu, Trevor Clancy, Mohsen Karimi, Sarah Cooley, Jeffrey S. Miller, Monika Klimkowska, Marie Schaffer, E...> ;Clinical Cancer Research. 2018 Apr 15
• 100 citations
  GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity.
  Frank Cichocki, Bahram Valamehr, Ryan Bjordahl, Bin Zhang, Betsy Rezner, Paul Rogers, Svetlana Gaidarova, Stacey K Moreno, Katie Tuininga, Phillip Dougherty, Valarie M...> ;Cancer Research. 2017 Oct 15
• Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.
  Hoff GA, Fischer JC, Hsu K, Cooley S, Miller JS, Wang T, Haagenson M, Spellman S, Lee SJ, Uhrberg M, Venstrom JM, Verneris MR> ;Biol. Blood Marrow Transplant.. 2017-01-01
• Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.
  Bergerson, R. J.,Williams, R.,Wang, H.,Shanley, R.,Colbenson, G.,Kerber, A.,Cooley, S.,Curtsinger, J.,Felices, M.,Miller, J. S.,Verneris, M. R.> ;Blood Adv. 2017 Dec 01
• Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation.
  He F, Verneris MR, Cooley S, Blazar BR, MacMillan ML, Newell LF, Panoskaltsis-Mortari A, DeFor T, Weisdorf DJ, Holtan SG> ;Bone Marrow Transplant.. 2016-11-21
• 36 citations
  Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation
  Veronika Bachanova, Daniel J. Weisdorf, Tao Wang, Steven G.E. Marsh, Elizabeth Trachtenberg, Michael Haagenson, Stephen R. Spellman, Martha Ladner, Lisbeth A. Guethlei...> ;Biology of Blood and Marrow Transplantation. 2016 Sep 1
• 132 citations
  Adaptive NK cells with low TIGIT expression are inherently resistant to myeloid-derived suppressor cells.
  Dhifaf Sarhan, Frank Cichocki, Bin Zhang, Ashley Yingst, Stephen R. Spellman, Sarah Cooley, Michael R. Verneris, Bruce R. Blazar, Jeffrey S. Miller> ;Cancer Research. 2016 Oct 1
• CD56(dim)CD57(+)NKG2C(+) NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.
  Cichocki, F.,Cooley, S.,Davis, Z.,DeFor, T. E.,Schlums, H.,Zhang, B.,Brunstein, C. G.,Blazar, B. R.,Wagner, J.,Diamond, D. J.,Verneris, M. R.,Bryceson, Y. T.,Weisdorf,...> ;Leukemia. 2015 Sep 30
• IL-15 Trispecific Killer Engagers (TriKEs) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing In Vivo Expansion, and Enhanced Function.
  Vallera, D. A.,Felices, M.,McElmurry, R. T.,McCullar, V.,Zhou, X.,Schmohl, J.,Zhang, B.,Lenvik, A.,Panoskaltsis-Mortari, A.,Verneris, M. R.,Tolar, J.,Cooley, S.,Weisdo...> ;Clin. Cancer Res.. 2016 Feb 06
• Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-Versus-Host Disease
  Margaret L MacMillan, Bruce R Blazar, Sarah Cooley, John E Wagner, David A Knorr, Daniel J Weisdorf, Claudio Brunstein, Michael R Verneris> ;Biology of Blood and Marrow Transplantation. 2016 Jan 26
• Join now to see all

Abstracts/Posters

• Results of a Phase I Study of Pnk-007, Allogeneic, Off the Shelf NK Cell, Post Autologous Transplant in Multiple Myeloma (NCT02955550)
  Sarah Cooley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Efficient Scale-up and Pre-Clinical Evaluation of NKG2C+ Adaptive NK Cell Expansion for Therapy Against High-Risk AML/MDS 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018